girl smiling

Patient Resources

girl smiling

Patient Resources

girl smiling

Patient
Resources

Patient Resources

Leadiant Biosciences, Inc. cares about patients and their families. That’s why we’ve created a range of resources meant to help those affected by cystinosis navigate the treatment process and stay on track with taking medication:

cystaran patient brochure image
cystaran patient brochure image

How-To Video

How-To Video

External Resources

cystinosis research foundation logo

Cystinosis Reasearch Foundation

cystinosis research network logo

Cystinosis Reasearch Network

genetic and rare diseases information center logo

Offices of Rare Disease Research

genetics home reference logo

Genetics Home Reference

national eye institute logo

National Eye Institute

national kidney foundation logo

National Kidney Foundation

national organization for rare disorders logo

National Organization for Rare Disorders

minus icon

IMPORTANT SAFETY INFORMATION

What is CYSTARAN?

CYSTARAN (cysteamine ophthalmic solution) 0.44% is an eyedrop medication used to treat cystine crystal accumulation in the corneas of patients who have cystinosis.

What is the most important safety information I should know about CYSTARAN?

  • To help prevent contamination of the dropper tip and eyedrop medication, try to make sure that CYSTARAN is dropped directly onto the eye without touching it. Try not to touch the eyelids or surrounding areas with the dropper tip of the bottle when you are using CYSTARAN. Keep the bottle tightly closed when not in use.
  • CYSTARAN contains an ingredient called benzalkonium chloride which can be absorbed by soft contact lenses. Remove contact lenses before using CYSTARAN eyedrops and wait at least 15 minutes before reinserting them.
  • CYSTARAN should only be used as an eyedrop medication.

What are the side effects of CYSTARAN?

  • The most common side effects of CYSTARAN, which have occurred in at least 10% of people using the medication, were sensitivity to light, eye redness, eye pain and irritation, and headache.

The risk information provided here is not comprehensive. To learn more, talk to your healthcare provider or pharmacist about CYSTARAN. The full FDA-approved product labeling can be found at www.cystaran.com.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call FDA at 1-800-FDA-1088.

plus icon

IMPORTANT SAFETY INFORMATION

What is CYSTARAN?

CYSTARAN (cysteamine ophthalmic solution) 0.44% is an eyedrop medication used to treat cystine crystal accumulation in the corneas of patients who have cystinosis.